Most important, even in patients with cirrhosis, previous IFN-based therapy was linked to a better clinical outcome in univariate analysis, which is in line with findings in patients with the HCV infection achieving suppression of viral replication by antiviral therapy [24]. The gene discussed is IFNA1; the disease is Cirrhosis.